Sort   by:  
 Page size 
UnknownSARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients.
Not available
S-EPMC10653322 | biostudies-literature
UnknownRespiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations.
Not available
S-EPMC9115297 | biostudies-literature
UnknownNeutrophil count predicts clinical outcome in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial.
Not available
S-EPMC8447398 | biostudies-literature
UnknownEvaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
Not available
S-EPMC8279143 | biostudies-literature
UnknownPersistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9.
Not available
S-EPMC8636497 | biostudies-literature
UnknownHigh Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19.
Not available
S-EPMC9384496 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
UnknownRemdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
Not available
S-EPMC9060606 | biostudies-literature
Sort   by:  
 Page size